LeafNLP Demos
Back to explore

Report #2873427

Received Nov 18, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
54 yrs
State
AL
Recovered
Unknown
Vaccinated
Nov 15, 2025
Onset
Nov 15, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNK5F5XK—

Symptoms (2)

Expired product administeredProduct administered to patient of inappropriate age

Symptom narrative

Expired dose given; 54 year old patient received Arexvy; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 54-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 5F5XK, expiry date 01-NOV-2025) for prophylaxis. On 15-NOV-2025, the patient received Arexvy. On 15-NOV-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Expired dose given) and inappropriate age at vaccine administration (Verbatim: 54 year old patient received Arexvy). The outcome of the expired vaccine used and inappropriate age at vaccine administration were not applicable. Additional Information: GSK Receipt Date: 17-NOV-2025 A pharmacist had contacted GlaxoSmithKline to report that a male patient had accidentally received a dose that had expired on 01-Nov-2025 on 15-Nov-2025.